Insights on the Asia-Pacific Long-Acting Bronchodilator Market to 2019 | Industry Statistics, Emerging Demands, Forecast to 2025

Asia-Pacific long-acting bronchodilator market is anticipated to grow at a substantial rate of 4.5% during the forecast period. Major factors that augment the growth of the market include a large population base susceptible to asthma and COPD, rising awareness about treatment for asthma and COPD, and the significant presence of market players in the region. Asia-Pacific has a potential market due to the increasing R&D and investments by major pharmaceutical companies in pharma and life science research coupled with harnessing innovation. The long-acting bronchodilator market in the Asia-Pacific region presents future opportunities for growth as the prevalence of respiratory diseases such as asthma, COPD in emerging economies such as India and China. In addition, increasing the geriatric population specially in Japan is another major reason for the growing market.

To Request a Sample of our Report on Asia-Pacific Long-Acting Bronchodilator Market: https://www.omrglobal.com/request-sample/asia-pacific-long-acting-bronchodilator-market

Asia-Pacific long-acting bronchodilator market is segmented on the basis of route of administration, application, and end-user. Based on the route of administration, the market is classified into oral, nasal, parenteral, and inhalation. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. The asthma disease application segment dominated the regional market in 2018 and is further estimated to follow the same trend over the forecast period. This is mainly due to the increasing pool of aging population susceptible to the high prevalence of asthma in the economies of the region such as China and India.

(Get 15% Discount on Buying this Report)

A full Report of Asia-Pacific Long-Acting Bronchodilator Market is Available @ https://www.omrglobal.com/industry-reports/asia-pacific-long-acting-bronchodilator-market

Asia-Pacific Long-Acting Bronchodilator Market Segmentation

By Route of Administration

· Oral

· Nasal

· Parenteral

· Inhalation

By Application

· Asthma

· Chronic Obstructive Pulmonary Disease (COPD)

By End-User

· Homecare

· Hospitals and Clinics

Regional Analysis

· China

· Japan

· India

Rest of Asia-Pacific

Company Profiles

· Adamis Pharmaceuticals Corp.

· AstraZeneca PLC

· Boehringer Ingelheim International GmbH

· GlaxoSmithKline PLC

· Novartis AG

· ResMed Corp.

· Pulmatrix Inc.

· Savara, Inc.

· Sunovion Pharmaceuticals

· Teva Pharmaceuticals Industries Ltd.

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.